Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Apr 29, 2024 | 15.66 | +3.92 |
Oak Valley Bancorp | OVLY | Apr 29, 2024 | 24.56 | +0.90 |
Oak Woods Acquisition | OAKU | Apr 29, 2024 | 10.77 | 0.00 |
Oaktree Capital A Pref | OAK-A | Apr 29, 2024 | 21.77 | +0.09 |
Oaktree Capital Group B Pref | OAK-B | Apr 29, 2024 | 21.51 | +0.05 |
Oaktree Specialty | OCSL | Apr 29, 2024 | 19.87 | +0.20 |
Oatly ADR | OTLY | Apr 29, 2024 | 1.00 | +0.50 |
Oblong | OBLG | Apr 29, 2024 | 0.12 | +5.17 |
OCA Acquisition A | OCAX | Apr 29, 2024 | 10.95 | +0.18 |
Occidental Petroleum | OXY | Apr 29, 2024 | 68.23 | +0.66 |
Ocean Biomedical | OCEA | Apr 29, 2024 | 1.57 | +17.16 |
Ocean Power Technologies | OPTT | Apr 29, 2024 | 0.20 | +5.26 |
Oceaneering International | OII | Apr 29, 2024 | 24.36 | -2.17 |
OceanFirst Financial | OCFC | Apr 29, 2024 | 14.99 | -2.47 |
OceanFirst Pref | OCFCP | Apr 29, 2024 | 24.13 | -1.67 |
OceanPal | OP | Apr 29, 2024 | 2.46 | +1.86 |
Ocugen | OCGN | Apr 29, 2024 | 1.39 | +8.59 |
Ocular Therapeutix | OCUL | Apr 29, 2024 | 4.80 | +1.16 |
Oculis | OCS | Apr 29, 2024 | 12.73 | +5.91 |
Ocuphire Pharma | OCUP | Apr 29, 2024 | 1.65 | +2.48 |
Ocwen Financial | OCN | Apr 29, 2024 | 24.63 | +1.23 |
Oddity Tech | ODD | Apr 29, 2024 | 32.55 | +1.12 |
Odyssey Marine Exploration | OMEX | Apr 29, 2024 | 3.52 | -0.28 |
Offerpad Solutions A | OPAD | Apr 29, 2024 | 7.59 | -8.44 |
Office Properties | OPI | Apr 29, 2024 | 2.09 | +3.98 |
OFG Bancorp | OFG | Apr 29, 2024 | 36.29 | -0.03 |
OFS Capital | OFS | Apr 29, 2024 | 9.52 | +0.69 |
OFS Credit | OCCI | Apr 29, 2024 | 7.05 | +0.21 |
OFS Credit C Pref | OCCIO | Apr 29, 2024 | 23.76 | -1.37 |
OFS Credit E Pref | OCCIN | Apr 29, 2024 | 22.95 | +0.26 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.